Clinical trial NCT05456100: Chinese American Cancer Survivors Writing Study
Official title: A Randomized Controlled Trial Testing Expressive Helping for Chinese American Cancer Survivors
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Cancer
Lead sponsor: New York University
Sponsor class: OTHER
Collaborators: name: National Institute on Minority Health and Health Disparities (NIMHD)
First posted: 2022-07-13
Enrollment: 108
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: The Chinese American Cancer Survivors Writing Study is a Randomized Controlled Trial (RCT) testing the feasibility and efficacy of the Expressive Helping (EH) intervention among Chinese American cancer survivors.

Detailed description: Chinese Americans are one of the fastest growing immigrant groups in the United States, but there is still a lack of culturally-sensitive and linguistically-appropriate resources and interventions for this group. To address this gap, the investigators will examine the efficacy and feasibility of Expressive Helping, a writing intervention designed to lead participants to write about their cancer experiences. Participants will be adult cancer survivors of Chinese descent. After screening and consent, eligible participants will be enrolled in a 1:1:1 randomized controlled trial. Assessments of psychological symptoms will occur at baseline (prior to randomization), 1-month post-intervention, 3-months post-intervention, and 6-months post-intervention.

Eligibility criteria: Inclusion Criteria:

* Over 18 years old.
* Prefer speaking in Mandarin Chinese or Cantonese, and able to read and write Simplified or Traditional Chinese.
* Within 5 years after completing primary treatment or have completed primary treatment but still on medication for managing cancer-related symptoms.

Exclusion Criteria:

* Difficulties with writing
* Current active participation in support groups (i.e., attending more than once per week)

Primary outcomes:
measure: Recruitment rates
timeFrame: through study completion, an average of 6 months
measure: Retention rates
timeFrame: through study completion, an average of 6 months
measure: Completion rate of writing sessions
timeFrame: through study completion, an average of 6 months
Secondary outcomes:
measure: Changes in depressive symptoms assessed by the Center for Epidemiologic Studies Depression Scale
timeFrame: Baseline to 1-month follow-up, 3-month follow-up, and 6-month follow-up
measure: Changes in anxiety symptoms assessed by the Generalized Anxiety Disorder Screener
timeFrame: Baseline to 1-month follow-up, 3-month follow-up, and 6-month follow-up
measure: Changes in health-related quality of life assessed by the Functional Assessment of Cancer Therapy: General (FACT-G).
timeFrame: Baseline to 1-month follow-up, 3-month follow-up, and 6-month follow-up
measure: Changes in perceived stress assessed by the Perceived Stress Scale.
timeFrame: Baseline to 1-month follow-up, 3-month follow-up, and 6-month follow-up
measure: Changes in cancer-related fatigue assessed by the Functional Assessment of Chronic Illness Therapy - Fatigue
timeFrame: Baseline to 1-month follow-up, 3-month follow-up, and 6-month follow-up
Other outcomes:
Locations:
city: New York
country: United States
facility: New York University
state: New York
Study officials:
References: